May the fibrosis be with you: Is discoidin domain receptor 2 the receptor we have been looking for?

Journal of Molecular and Cellular Cardiology

Volumn 91, Issue , 2016, Pages 201-203

  DeLeon Pennell, Kristine Y ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Discoidin domain receptor 2; Fibroblast; Fibrosis

Indexed keywords

ANGIOTENSIN II; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DISCOIDIN; DISCOIDIN DOMAIN RECEPTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; UNCLASSIFIED DRUG; ANGIOTENSIN RECEPTOR ANTAGONIST; COLLAGEN; DISCOIDIN DOMAIN RECEPTOR; LECTIN RECEPTOR; LOSARTAN; PROTEIN TYROSINE KINASE;

CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; EDITORIAL; HEART FIBROBLAST; HEART MUSCLE FIBROSIS; HUMAN; NEGATIVE FEEDBACK; NONHUMAN; OSTEOBLAST; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; CARDIAC MUSCLE; FIBROBLAST; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONISTS; COLLAGEN; DISCOIDIN DOMAIN RECEPTORS; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; LOSARTAN; MYOCARDIUM; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, MITOGEN; SIGNAL TRANSDUCTION;

EID: 84961364903     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2016.01.006     Document Type: Editorial

References (41)

1. George M., Vijayakumar A., Dhanesh A.B., James J., Shivakumar K. Molecular basis and functional significance of Angiotensin II-induced increase in Discoidin Domain Receptor 2 gene expression in cardiac fibroblasts. J. Mol. Cell. Cardiol. 2015.
2. Ducharme A., Frantz S., Aikawa M., Rabkin E., Lindsey M., Rohde L.E., et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J. Clin. Invest. 2000, 106:55-62.
3. Jourdan-Lesaux C., Zhang J., Lindsey M.L. Extracellular matrix roles during cardiac repair. Life Sci. 2010, 87:391-400.
4. Chiao Y.A., Ramirez T.A., Zamilpa R., Okoronkwo S.M., Dai Q., Zhang J., et al. Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice. Cardiovasc. Res. 2012, 96:444-455.
5. Ma Y., de Castro Bras L.E., Toba H., Iyer R.P., Hall M.E., Winniford M.D., et al. Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling. Pflugers Arch. 2014.
6. Silzle T., Randolph G.J., Kreutz M., Kunz-Schughart L.A. The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int. J. Cancer 2004, 108:173-180.
7. Smith R.S., Smith T.J., Blieden T.M., Phipps R.P. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am. J. Pathol. 1997, 151:317-322.
8. Dahlof B., Zanchetti A., Diez J., Nicholls M.G., Yu C.M., Barrios V., et al. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy. J. Hypertens. 2002, 20:1855-1864.
9. Diez J., Querejeta R., Lopez B., Gonzalez A., Larman M., Martinez Ubago J.L. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002, 105:2512-2517.
10. Lim D.S., Lutucuta S., Bachireddy P., Youker K., Evans A., Entman M., et al. Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation 2001, 103:789-791.
11. Weber K.T. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation 1997, 96:4065-4082.
12. Olaso E., Lin H.C., Wang L.H., Friedman S.L. Impaired dermal wound healing in discoidin domain receptor 2-deficient mice associated with defective extracellular matrix remodeling. Fibrogenesis Tissue Repair 2011, 4:5.
13. Badiola I., Villace P., Basaldua I., Olaso E. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability. Oncol. Rep. 2011, 26:971-978.
14. Olaso E., Arteta B., Benedicto A., Crende O., Friedman S.L. Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liver-associated macrophages. Am. J. Pathol. 2011, 179:2894-2904.
15. Leitinger B. Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2. J. Biol. Chem. 2003, 278:16761-16769.
16. Vogel W., Gish G.D., Alves F., Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell 1997, 1:13-23.
17. Olaso E., Ikeda K., Eng F.J., Xu L., Wang L.H., Lin H.C., et al. DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J. Clin. Invest. 2001, 108:1369-1378.
18. Ikeda K., Wang L.H., Torres R., Zhao H., Olaso E., Eng F.J., et al. Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen. J. Biol. Chem. 2002, 277:19206-19212.
19. Olaso E., Labrador J.P., Wang L., Ikeda K., Eng F.J., Klein R., et al. Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2. J. Biol. Chem. 2002, 277:3606-3613.
20. Xu L., Peng H., Wu D., Hu K., Goldring M.B., Olsen B.R., et al. Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. J. Biol. Chem. 2005, 280:548-555.
21. Adair-Kirk T.L., Senior R.M. Fragments of extracellular matrix as mediators of inflammation. Int. J. Biochem. Cell Biol. 2008, 40:1101-1110.
22. Lindsey M.L., Iyer R.P., Zamilpa R., Yabluchanskiy A., DeLeon-Pennell K.Y., Hall M.E., et al. A novel collagen matricryptin reduces left ventricular dilation post-myocardial infarction by promoting scar formation and angiogenesis. J. Am. Coll. Cardiol. 2015, 66:1364-1374.
23. Gardi C., Calzoni P., Marcolongo P., Cavarra E., Vanni L., Lungarella G. Collagen breakdown products and lung collagen metabolism: an in vitro study on fibroblast cultures. Thorax 1994, 49:312-318.
24. Wang M., Zhao D., Spinetti G., Zhang J., Jiang L.Q., Pintus G., et al. Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1503-1509.
25. Yu Q., Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000, 14:163-176.
26. Flynn L.A., Blissett A.R., Calomeni E.P., Agarwal G. Inhibition of collagen fibrillogenesis by cells expressing soluble extracellular domains of DDR1 and DDR2. J. Mol. Biol. 2010, 395:533-543.
27. Mihai C., Iscru D.F., Druhan L.J., Elton T.S., Agarwal G. Discoidin domain receptor 2 inhibits fibrillogenesis of collagen type 1. J. Mol. Biol. 2006, 361:864-876.
28. Labrador J.P., Azcoitia V., Tuckermann J., Lin C., Olaso E., Manes S., et al. The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep. 2001, 2:446-452.
29. Kawai I., Hisaki T., Sugiura K., Naito K., Kano K. Discoidin domain receptor 2 (DDR2) regulates proliferation of endochondral cells in mice. Biochem. Biophys. Res. Commun. 2012, 427:611-617.
30. Zhang Y., Su J., Yu J., Bu X., Ren T., Liu X., et al. An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2011, 26:604-617.
31. Ikeda K., Wakahara T., Wang Y.Q., Kadoya H., Kawada N., Kaneda K. In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation. Hepatology 1999, 29:1760-1767.
32. Hakkinen K.M., Harunaga J.S., Doyle A.D., Yamada K.M. Direct comparisons of the morphology, migration, cell adhesions, and actin cytoskeleton of fibroblasts in four different three-dimensional extracellular matrices. Tissue Eng. A 2011, 17:713-724.
33. Xu J., Clark R.A. Extracellular matrix alters PDGF regulation of fibroblast integrins. J. Cell Biol. 1996, 132:239-249.
34. De Mello W.C., Specht P. Chronic blockade of angiotensin II AT1-receptors increased cell-to-cell communication, reduced fibrosis and improved impulse propagation in the failing heart. J. Renin Angiotensin Aldosterone Syst. 2006, 7:201-205.
35. Shibasaki Y., Nishiue T., Masaki H., Tamura K., Matsumoto N., Mori Y., et al. Impact of the angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: assessment by ultrasonic integrated backscatter and biochemical markers. Hypertens. Res. 2005, 28:787-795.
36. Pitt B., Segal R., Martinez F.A., Meurers G., Cowley A.J., Thomas I., et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997, 349:747-752.
37. Nobakht N., Kamgar M., Rastogi A., Schrier R.W. Limitations of angiotensin inhibition. Nat. Rev. Nephrol. 2011, 7:356-359.
38. Wolf G., Ritz E. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int. 2005, 67:799-812.
39. Baltatzi M., Savopoulos C., Hatzitolios A. Role of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension of chronic kidney disease and renoprotection. Study results. Hippokratia 2011, 15:27-32.
40. Senbonmatsu T., Saito T., Landon E.J., Watanabe O., Price E., Roberts R.L., et al. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J. 2003, 22:6471-6482.
41. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ. Res. 1998, 83:1182-1191.